LA JOLLA, CA, April 30, 2024 – Enlaza Therapeutics, the first covalent biologic platform company, today announced a $100 million Series A financing. The financing will be used to further...
Art Pappas joins a panel at the 2013 BIO International Convention in Chicago titled, "Money Ball - Winning Venture Strategies."
News | 03. 19. 2013
Art Pappas joins a panel at the 2013 BIO International Convention in Chicago titled, "Money Ball - Winning Venture Strategies."
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.